MLYS vs JNJ: Which Stock is Better?

Side-by-side comparison of Mineralys Therapeutics, Inc. Common Stock and Johnson & Johnson in 2026

Comparison Updated:

MLYS

Mineralys Therapeutics, Inc. Common Stock

$31.93

JNJ

Johnson & Johnson

$218.21

Key Metrics Comparison

MetricMLYSJNJWinner
Market Cap$2.53B$525.73BJNJ
P/E RatioN/A21.10JNJ
EPS (TTM)$N/A$10.34JNJ
Revenue Growth0.0%0.1%JNJ
Gross Margin0.0%68.4%JNJ

Analyze MLYS

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MLYS or JNJ a better investment?

Comparing MLYS and JNJ: Mineralys Therapeutics, Inc. Common Stock has a market cap of $2.53B while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MLYS and JNJ?

MLYS (Mineralys Therapeutics, Inc. Common Stock) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MLYS or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MLYS or JNJ?

JNJ has higher revenue growth at 0.1% vs 0.0% for MLYS.

Which company is more profitable: MLYS or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.4% compared to 0.0% for MLYS.

Which is the larger company: MLYS or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $2.53B for MLYS.

Should I buy MLYS or JNJ in 2026?

Both MLYS and JNJ have investment merit. MLYS trades at $31.93 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MLYS and JNJ stock?

Key differences: Market Cap ($2.53B vs $525.73B), P/E Ratio (N/A vs 21.1x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 68.4%).

Popular Stock Comparisons